Guardant Health Inc (GH) is around the middle of the Diagnostics & Research industry according to InvestorsObserver. GH received an overall rating of 41, which means that it scores higher than 41 percent of all stocks. Guardant Health Inc also achieved a score of 54 in the Diagnostics & Research industry, putting it above 54 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 81 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 41 would rank higher than 41 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Guardant Health Inc Stock Today?
Guardant Health Inc (GH) stock is trading at $125.63 as of 2:20 PM on Thursday, Jun 17, a rise of $8.44, or 7.2% from the previous closing price of $117.19. The stock has traded between $116.11 and $125.86 so far today. Volume today is 848,199 compared to average volume of 1,099,861.
Click Here to get the full Stock Score Report on Guardant Health Inc (GH) Stock.
